• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    BASi Appoints COO

    Nestlé Health Licenses Codexis’ CDX-6114

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Progenics Launches Mfg. Ops in NJ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Progenics Launches Mfg. Ops in NJ

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Haselmeier Acquires Drug Manufacturing License

    Emerald Health, Lonza Enter Large-Scale Mfg. Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Recipharm Facilities Ready for EU Serialization

    Andrew Alliance, Sartorius Launch Research Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nestlé Health Licenses Codexis’ CDX-6114

    Personalized Medicine: Getting More Out of Clinical Trials

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    Charles River to Pay $510M for Citoxlab

    West, Swissfillon Enter Drug Delivery Partnership
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Jubilant HollisterStier Contract Manufacturing & Services

    Federal Equipment Company

    Emergent BioSolutions, Inc.

    Ascendia Pharmaceuticals

    Aphena Pharma Solutions, Inc.
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane, Inc.

    Ascendia Pharmaceuticals

    Federal Equipment Company

    Baxter BioPharma Solutions

    Emergent BioSolutions, Inc.
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    WCG and InformedDNA Enter Strategic Partnership

    To create a “Center for Genetics and Precision Medicine in Clinical Trials” for the conduct of genetics related trials

    Related CONTENT
    • PharmaMar, Megapharm Partner for Multiple Myeloma
    • Merus, Simcere Enter Bispecific Antibodies Alliance
    • Syapse, Roche Enter Precision Medicine Pact
    • Biorasi Opens Japan Office
    • Preparing for Precision Medicine
    06.27.18

    WCG (WIRB-Copernicus Group) Clinical Services Division has entered a strategic partnership with InformedDNA, the nation's largest independent provider of genetics expert services. 

    Through this partnership, the companies will create the “Center for Genetics and Precision Medicine in Clinical Trials” to support biopharmaceutical companies, contract research organizations (CROs), institutions and investigator sites in the design and conduct of clinical trials that use genetics.

    “Precision medicine demands that we rethink the traditional drug development process,” said Donald A. Deieso, PhD, executive chairman and chief executive officer of WCG. “The disease, as well as the proposed treatment, must be carefully considered in the context of the patient’s individual genetic makeup. To that end, we are delighted to partner with InformedDNA to introduce genetic-oriented clinical trial solutions that will support our clients as they work to deliver the extraordinary promise of precision medicine.”

    Under the strategic partnership, WCG and InformedDNA will launch the Center for Genetics and Precision Medicine in Clinical Trials, which will unite InformedDNA’s substantial genetics resources and expertise with WCG’s global network of 550 experts in clinical trial optimization and its proprietary industry Knowledge BaseTM. The companies aim to tackle the challenges and opportunities of applying genetic information in trial and protocol design as well as harness the power of genetics to identify, recruit, and manage patients in clinical trials.

    “With the rise in precision medicine, protocols have become increasingly complex,” said David Nixon, chairman and chief executive officer of InformedDNA. “This complexity presents challenges in the design of clinical trials that include genetic components, but also the opportunity to uncover greater value in the process through a proper genetic focus. Through our partnership with WCG, we will teach research sponsors how to effectively apply genetic expertise to their studies so that they can derive the most value from their research.”

    The companies will offer a genetics and clinical development solution to optimize the design of protocols and to ensure that all genetic information is appropriately applied to study design. The solution will enable sponsors to identify hard-to-find patient populations, reduce their exposure to risk, identify broader potential therapeutic indications, and increase the overall value of each trial subject.

     
    Related Searches
    • study
    • chief executive officer
    • biopharmaceutical companies
    • Clinical Trial
    Suggested For You
    The Chain of Compliance The Chain of Compliance
    GE, XPH Enter FlexFactory Agreement GE, XPH Enter FlexFactory Agreement
    Ready for ASCO Ready for ASCO
    ACM Global Labs Adds New Testing Services for Oncology Trials   ACM Global Labs Adds New Testing Services for Oncology Trials
    CRO Perspectives: PAREXEL CRO Perspectives: PAREXEL
    WCG Clinical Opens Office in Tokyo WCG Clinical Opens Office in Tokyo
    CRO Trends: IQVIA Perspective  CRO Trends: IQVIA Perspective
    CRO Industry Update: Big Data Drives Drug Development Efforts CRO Industry Update: Big Data Drives Drug Development Efforts
    PITT, Thermo Fisher Form Pharmacogenomics Center of Excellence PITT, Thermo Fisher Form Pharmacogenomics Center of Excellence
    Dalton, Oryn Therapeutics in Development, Mfg. Pact Dalton, Oryn Therapeutics in Development, Mfg. Pact
    Biologic Sample Management in R&D Biologic Sample Management in R&D
    Preparing for Precision Medicine Preparing for Precision Medicine
    Biorasi Opens Japan Office Biorasi Opens Japan Office
    Syapse, Roche Enter Precision Medicine Pact Syapse, Roche Enter Precision Medicine Pact
    Merus, Simcere Enter Bispecific Antibodies Alliance Merus, Simcere Enter Bispecific Antibodies Alliance

    Related Breaking News

    • Breaking News | Drug Development | Industry News
      Nestlé Health Licenses Codexis’ CDX-6114

      Nestlé Health Licenses Codexis’ CDX-6114

      Novel, oral enzyme for phenylketonuria is Codexis’ first internally developed biotherapeutic candidate
      02.19.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      Mark Altmeyer named president and chief executive of Arvelle
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
      Passage Bio Officially Launches

      Passage Bio Officially Launches

      With $115.5M Series A, to develop AAV-delivered therapeutics to treat rare monogenic CNS diseases
      02.15.19


    • Bio News | Collaborations & Alliances | Drug Development | Industry News | Methods Development | R&D
      Axovant Announces Formation of Arvelle Therapeutics

      Axovant Announces Formation of Arvelle Therapeutics

      Along with the strategic transition of legacy small molecule team into the newly formed company
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      AbCellera & Novartis Announce Collaboration

      AbCellera & Novartis Announce Collaboration

      AbCellera to apply technology to advance programs on up to ten targets elected by Novartis
      02.15.19

    • Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      NeoTX, MedImmune Announce Clinical Collaboration

      NeoTX, MedImmune Announce Clinical Collaboration

      To support Phase 1b/2 studies investigating ANYARA in combination with AstraZeneca's IMFINZI
      02.11.19


    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Eton & Sintetica Enter Supply Agreement

      Eton & Sintetica Enter Supply Agreement

      To obtain U.S. marketing rights to two high-volume, near-term product launch candidates.
      02.11.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      3SBio, Verseau Establish Immuno-Oncology Devt. Collaboration

      3SBio, Verseau Establish Immuno-Oncology Devt. Collaboration

      3SBio will fund and conduct antibody development and GMP manufacturing
      02.11.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      MedPharm & Palvella Expand Partnership

      MedPharm & Palvella Expand Partnership

      For developing a new treatment for the debilitating rare disease, pachyonychia congenita
      02.11.19


    • Breaking News | Drug Development | Industry News
      IFM Therapeutics Launches Subsidiary

      IFM Therapeutics Launches Subsidiary

      IFM Due to advance cGAS/STING antagonists for serious inflammatory and autoimmune diseases
      02.11.19

    • Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
      Pathios, Sygnature Announce Partnership

      Pathios, Sygnature Announce Partnership

      For an integrated drug discovery program against a novel G Protein-Coupled Receptor (GPCR) target
      02.07.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Evotec & Galapagos Enter Global Collaboration

      Evotec & Galapagos Enter Global Collaboration

      Focused on a novel target for fibrosis and other indications
      02.07.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      EMD Serono Expands Bio R&D Facility

      EMD Serono Expands Bio R&D Facility

      Will invest $70 million to expand Billerica, MA facility with a new 145,000 sq.-ft. building
      02.06.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      MilliporeSigma Funds Small Biotechs

      MilliporeSigma Funds Small Biotechs

      Awards grants to biotechs tackling cancer and cardiovascular disease
      02.05.19

    • Bio News | Collaborations & Alliances | Drug Development | Industry News
      Taiho and Cullinan Enter Cancer Collaboration

      Taiho and Cullinan Enter Cancer Collaboration

      Will develop TAS6417, novel EGFR tyrosine kinase inhibitor
      02.05.19

    Breaking News
    • BASi Appoints COO
    • Nestlé Health Licenses Codexis’ CDX-6114
    • SK, Arvelle Sign $530M Deal for Antiepileptic Drug
    • GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers
    • Progenics Launches Mfg. Ops in NJ
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login